Moreover, the anti-inflammatory effects of PRP may mitigate elevated inflammatory markers observed in melasma-affected skin, such as interleukin-17 (IL-17), CD4-positive T cells, and cyclooxygenase-2 (COX-2) [169,170]. The gene discussed is IL17A; the disease is freckles.